Akabane Miho, Hashimoto Masaji, Takazawa Yutaka, Hattori Daisuke, Koyama Rikako, Imamura Tsunao
Division of Hepatobiliary-Pancreatic Surgery, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo 105-8470, Japan.
Department of Pathology, Toranomon Hospital, Tokyo 105-8470, Japan.
Mol Clin Oncol. 2022 Feb;16(2):35. doi: 10.3892/mco.2021.2468. Epub 2021 Dec 16.
Diagnosing leiomyosarcomas of the splenic vein is challenging, and a treatment strategy has not yet been established for this condition. We herein report the case of a 45-year-old female patient with a history of retinoblastoma who underwent pancreatosplenectomy for a primary leiomyosarcoma originating from the splenic vein and transcatheter arterial chemoembolization for metastatic hepatic lesions observed 5 months postoperatively. An initial medical check-up using abdominal ultrasound revealed a 40-mm mass behind the pancreatic tail. Imaging tests revealed a well-circumscribed mass compressing the pancreas posteriorly, without invasion into the pancreatic duct. The splenic vein was torn, with the epiploic veins developed as collateral blood vessels, which was an atypical finding for carcinoma. The patient was followed up regularly. At 5 years after the first visit, an abdominal ultrasound showed that the mass had increased in size to 50 mm, and had developed into a tumor embolus within the splenic vein, causing an obstruction of the vessel. Pancreatosplenectomy was performed due to suspicion of malignancy. The final diagnosis was leiomyosarcoma arising from the splenic vein. The patient was discharged on postoperative day 15 and was followed up regularly thereafter. Imaging studies performed 5 months postoperatively revealed four hepatic lesions. The hepatic masses were histologically diagnosed as metastatic leiomyosarcomas, and transcatheter arterial chemoembolization was performed using epirubicin. Since then, regular follow-ups have been conducted without observed recurrence. Leiomyosarcoma of the splenic vein is exceedingly rare, and the number of reported cases is not sufficient to establish clinical guidelines. Therefore, it is crucial to collect more reports on the occurrence and treatment of this disease.
诊断脾静脉平滑肌肉瘤具有挑战性,目前尚未针对这种情况制定出治疗策略。我们在此报告一例45岁患有视网膜母细胞瘤病史的女性患者,她因起源于脾静脉的原发性平滑肌肉瘤接受了胰脾切除术,并在术后5个月对观察到的肝脏转移病灶进行了经导管动脉化疗栓塞术。最初的腹部超声检查发现胰尾后方有一个40毫米的肿块。影像学检查显示有一个边界清晰的肿块向后压迫胰腺,未侵犯胰管。脾静脉撕裂,胃网膜静脉形成侧支血管,这是癌症的非典型表现。对该患者进行了定期随访。首次就诊5年后,腹部超声显示肿块增大至50毫米,并发展为脾静脉内的肿瘤栓子,导致血管阻塞。由于怀疑为恶性肿瘤,遂进行了胰脾切除术。最终诊断为起源于脾静脉的平滑肌肉瘤。患者术后第15天出院,此后进行定期随访。术后5个月的影像学检查发现有4个肝脏病灶。肝脏肿块经组织学诊断为转移性平滑肌肉瘤,并使用表柔比星进行了经导管动脉化疗栓塞术。从那时起,进行了定期随访,未观察到复发。脾静脉平滑肌肉瘤极为罕见,报告的病例数量不足以建立临床指南。因此,收集更多关于这种疾病的发生和治疗的报告至关重要。